Takahashi_2001_J.Cardiovasc.Pharmacol_37_209

Reference

Title : Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium - Takahashi_2001_J.Cardiovasc.Pharmacol_37_209
Author(s) : Takahashi R , Endoh M
Ref : J Cardiovasc Pharmacol , 37 :209 , 2001
Abstract :

We performed experiments in canine ventricular trabeculae loaded with aequorin to elucidate the mechanism of positive inotropic effect of UD-CG 212 Cl (4,5-dihydro-6-[2-(4-hydroxyphenyl)-1H-benzimidazole-5-yl]-5-methyl-3(2H)-pyridaz inone), an active metabolite of pimobendan. The maximum response to UD-CG 212 Cl achieved at 10(-5) M was 18% of ISOmax and it was associated with an increase in Ca2+ transients of 7% of ISOmax. For a given increase in force, the increase in Ca2+ transients induced by UD-CG 212 Cl was less than that induced by elevation of [Ca2+]o. The positive inotropic effect of UD-CG 212 Cl was not associated with an impairment of relaxation and it was abolished by carbachol. In conclusion, UD-CG 212 Cl has a positive inotropic effect partly due to an increase in myofibrillar Ca2+ sensitivity that is exerted via cross talk with a signal transduction pathway that involves cAMP.

PubMedSearch : Takahashi_2001_J.Cardiovasc.Pharmacol_37_209
PubMedID: 11210003

Related information

Citations formats

Takahashi R, Endoh M (2001)
Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium
J Cardiovasc Pharmacol 37 :209

Takahashi R, Endoh M (2001)
J Cardiovasc Pharmacol 37 :209